PubMed Central · 1998 · 26 citations · 21 references
Open access
MedicineOncologyBreast OncologyCancer ControlCancer PreventionBreast-conserving TherapyMalignant NeoplasmsResearch ArticlesResearch Summaries
This article, on Iscador, is third in the series that reviews the evidence for the safety and effectiveness of 6 unconventional therapies commonly used by Canadian cancer patients. The purpose and methodology of the review of these therapies appear in part 1 (CMAJ 1998[7]:897-902). Annotated bibliographies providing more detailed references are available in print from the Canadian Breast Cancer Research Initiative (CBCRI; address appears at end of article). The reference lists and the lay summaries of the findings (published in 1997) can be found on the CBCRI’s Web site (www.breast.cancer.ca). The following article adapts the lay summary of information on Iscador for clinicians and provides references for the key findings. [Copies of this and other articles in the series can be found on CMAJ’s Web site (www.cma.ca/cmaj/series/therapy.htm).]
21
CRC Handbook of Medicinal Herbs
J. A. Duke · International Clinical Psychopharmacology · 1990 · 507 citations
Life Sciences, Botany, Toxicology +14
Mistletoe treatment for cancer review of controlled trials in humans
Jos Kleijnen, P. Knipschild · Phytomedicine · 1994 · 161 citations
Action of viscumin, a toxic lectin from mistletoe, on cells in culture.
Fiorenzo Stirpe, Kirsten Sandvig, Sjur Olsnes et al. · Journal of Biological Chemistry · 1982 · 105 citations · Full text
Immunomodulatory Effects of Iscador: A Viscum album Preparation
Tibor Hajtò · Oncology · 2009 · 88 citations
Life Sciences, Immunology, Oncology +17